Pharmaceutical Intermediates
Full official intermediate catalog + key intermediates with CEP / DMF / GMP / cold-chain qualifications and capacity details · each quotable via RFQ
Featured ProductsProven track record · documents on request
Enter hub →Orforglipron intermediates
Sample orders (500 g each) + 0.5 kg repeat order
Dealt 1–4 · latest 2026-09
Documents in progress
PINACOLONE
Dual-use item (trade control category)
Dealt 1–4 · latest 2026-01
Documents in progress
4-(3-Bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
CAS 543737-10-6
Dealt 1–4 · latest 2026-07
Documents in progress
L-Tyrosine disodium salt, dihydrate
100–199 deals · latest 2026-09
Open for inquiry →
D-Glucose Anhydrous
100–199 deals · latest 2026-09
Open for inquiry →
Choline chloride
CAS 67-48-1
100–199 deals · latest 2026-09
Open for inquiry →
2026 Key Intermediate Campaigns →
4 target drugs · 7 key intermediatesAntiviral (HIV-1)
Metabolic (obesity / type 2 diabetes)
Oncology (breast cancer)
Endocrine (Cushing's syndrome)
Patent-cliff opportunities · recommended intermediates
Ranked by opportunity score · source: patent-cliff radarOpen opportunity profile →semaglutide
68Intermediate list in preparation — inquiries welcome
Key opportunity markets: India / Bangladesh / Pakistan
olaparib
66Key opportunity markets: United States / Canada / Mexico
apixaban
62Key opportunity markets: United Kingdom / Germany / Italy
sacubitril/valsartan
62Intermediate list in preparation — inquiries welcome
Key opportunity markets: China / Japan / South Korea
tirzepatide
61Key opportunity markets: China / Japan / South Korea
sacubitril/valsartan
61Intermediate list in preparation — inquiries welcome
Key opportunity markets: United States / Canada / Mexico
Region is inferred coarsely from your browser IP (region-level only, IP not stored). Opportunity scores are internal radar ratings, not a commitment.
By Therapeutic Area of Target Drug
Click a class to filter both sections below; classes follow the target API's primary indicationDiabetes, obesity, dyslipidemia, NASH and other metabolic diseases
Hypertension, heart failure, anticoagulation, chronic kidney disease
Solid tumours, haematologic malignancies, myeloproliferative diseases
Antiviral, antibacterial, antifungal, HIV / hepatitis
RA, psoriasis, atopic dermatitis, IBD
Epilepsy, pain, depression & anxiety, neurodegeneration
Acid-related, GI motility, diarrhoea, liver disease
COPD, asthma and other airway diseases
Menopausal symptoms, urological conditions
Glaucoma, ocular surface disease
Skin infection, dermatologic inflammation
Local anaesthesia, postoperative analgesia
Allergic rhinitis, urticaria
Companion-animal ectoparasiticides